Clinical Trials · NCT05459285
A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Enrollment
- 68
- Start date
- May 2022
- Locations
- 1 site, China
- Primary endpoint
- Maximum (peak) plasma drug concentration(Cmax)